Asia-Pacific Dietary Supplement Market - Growth, Trends, and Forecast (2019-2024)

SKU ID :INH-13517629 | Published Date: 01-May-2019 | No. of pages: 100
1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 3.1 Market Overview 4 MARKET DYNAMICS 4.1 Market Drivers 4.2 Market Restraints 4.3 Porter's Five Forces Analysis 4.3.1 Threat of New Entrants 4.3.2 Bargaining Power of Buyers/Consumers 4.3.3 Bargaining Power of Suppliers 4.3.4 Threat of Substitute Products 4.3.5 Intensity of Competitive Rivalry 5 MARKET SEGMENTATION 5.1 By Ingredient 5.1.1 Vitamins 5.1.2 Botanicals 5.1.3 Minerals 5.1.4 Amino Acids 5.1.5 Enzymes 5.1.6 Protein 5.1.7 Other Ingredients 5.2 By End User 5.2.1 Adult 5.2.2 Infant 5.2.3 Children 5.2.4 Pregnant Women 5.2.5 Elderly 5.3 Geography 5.3.1 China 5.3.2 Japan 5.3.3 India 5.3.4 South Korea 5.3.5 Australia 5.3.6 Rest of Asia-Pacific 6 COMPETITIVE LANDSCAPE 6.1 Most Active Companies 6.2 Most Adopted Strategies 6.3 Market Share Analysis 6.4 Company Profiles 6.4.1 Abbott Laboratories 6.4.2 The Carlyle Group 6.4.3 Bayer AG 6.4.4 GlaxoSmithKline PLC 6.4.5 Amway Corporation 6.4.6 Glanbia, Plc 6.4.7 Pfizer Inc. 6.4.8 Archer Daniels Midland Company 7 MARKET OPPORTUNITIES AND FUTURE TRENDS
- Abbott Laboratories - The Carlyle Group - Bayer AG - GlaxoSmithKline PLC - Amway Corporation - Glanbia, Plc - Pfizer Inc. - Archer Daniels Midland Company
  • PRICE
  • $3850
    $8250

Our Clients